Advanced Biomed agrees to acquire Acellent Technologies for 270K shares valued at $1.08M

Advanced Biomed Inc.

Acquiring 100% of Acellent Technologies (Hong Kong), an AI-powered financial verification company.
Purchase price: 270,000 shares of ADVB common stock valued at $4.00/share, total $1,080,000.
Closing subject to completion of due diligence and receipt of regulatory approvals.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.